Neochem Bio — 360° view

Neochem Bio, a company in the Specialty Chemicals industry, reported revenue of ₹69 crore and net profit of ₹8.00 crore for the September 2026 quarter.

Neochem Bio (NSE: NEOCHEM-SM) closed at ₹103.00 on 20 Nov 2026. Its market capitalisation is ₹176 crore and it trades at 11.6 times earnings.

Share price
₹103.00 (20 Nov 2026)
Market cap
₹176 Cr (20 Nov 2026)
P/E
11.64 (20 Nov 2026)
Revenue
₹69 Cr (September 2026 quarter)
Net profit
₹8 Cr (September 2026 quarter)
ROCE
28.1% (FY26)
ROE
25.4% (FY26)
Book value
₹50.6 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹118.80 / ₹89.95 (20 Nov 2026)
Sector
Commodities
Industry
Specialty Chemicals
Symbol
NSE: NEOCHEM-SM

Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.